EGFR and KRAS mutation status in non-small-cell lung cancer occurring in HIV-infected patients.

@article{Crquit2016EGFRAK,
  title={EGFR and KRAS mutation status in non-small-cell lung cancer occurring in HIV-infected patients.},
  author={Perrine Cr{\'e}quit and A M Ruppert and Nathalie Rozensztajn and Val{\'e}rie Gounant and T Vieira and Virginie Poulot and Martine Antoine and Christos Chouaid and Marie Wislez and Jacques L Cadranel and Armelle Lavol{\'e}},
  journal={Lung cancer},
  year={2016},
  volume={96},
  pages={
          74-7
        }
}
  • Perrine Créquit, A M Ruppert, +8 authors Armelle Lavolé
  • Published in Lung cancer 2016
  • Medicine
  • Non-small-cell lung cancer (NSCLC) is the most common non-acquired immune deficiency syndrome-related malignancy responsible for death. Mutational status is crucial for choosing treatment of advanced NSCLC, yet no data is available on the frequency of epidermal growth factor receptor (EGFR) and Kirsten ras (KRAS) mutations and their impact on NSCLC in human immunodeficiency virus (HIV)-infected patients (HIV-NSCLC). All consecutive HIV-NSCLC patients diagnosed between June 1996 and August 2013… CONTINUE READING

    Create an AI-powered research feed to stay up to date with new papers like this posted to ArXiv

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 16 REFERENCES

    Survival among HIV-infected and HIV-uninfected individuals with common non-AIDS-defining cancers.

    • Julia L Marcus, Chun R. Chao, +8 authors M J Silverberg
    • Medicine
    • Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
    • 2015
    VIEW 1 EXCERPT

    Group AEMS

    • P. Morlat, C. Roussillon, +11 authors G. Chene
    • Causes of death among HIV-infected patients in France in 2010 (national survey): trends since 2000, AIDS (London, England), 28,
    • 2014
    VIEW 1 EXCERPT